Patient Recruitment for Rare Disease Trials Summit
Recruiting patients for rare disease trials is akin to finding a needle in a haystack, with challenges such as geographical dispersion, low awareness, and limited eligible patient pools. It comes as no surprise that more than 80% of clinical trials in the U.S fail to meet their patient enrolment times.
The Patient Recruitment for Rare Disease Trials Summit addresses these obstacles head-on by exploring innovative strategies to identify and engage eligible participants more efficiently.
Bursting with real-world evidence and implementable case studies, this platform offers a unique exploration of both the hottest topics and industry bottlenecks, including:
- EXPLORE actionable insights for enhancing DE&I with Biogen to ensure everyone, regardless of background, can benefit from clinical research
- GAIN knowledge on how patient feedback can be gathered, and then integrated back into trial design as they progress with Day One Biopharmaceuticals
- NAVIGATE best practices when it comes to sharing sensitive, clinical trial data with patient organisations to build trusting, transparent relationships with Astellas Pharma
- ENRICH your understanding of ensuring fair patient reimbursement with Reata Pharmaceuticals without compromising limited trial budgets
View the 22+ expert speakers here from the likes of Novo Nordsik, Biogen, Astellas, Sanofi, Travere Therapeutics and Reata Pharmaceuticals.
You can register here while discounts last and take advantage of group discount of up to 20% when you bring your colleagues.
Don't miss the chance to collaborate with industry experts working towards a common goal: ensuring that patients with rare diseases have access to life-changing therapies!
